NCT01845818View on ClinicalTrials.gov

Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

June 5, 2013

Primary Completion Date

June 23, 2017

Study Completion Date

June 23, 2017

Conditions
Ankylosing SpondylitisPsoriatic Arthritis
Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT01845818 - Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium | Biotech Hunter | Biotech Hunter